New SGLT2 Inhibitor Gains FDA Approval for Type 2 Diabetes

(MedPage Today) -- The first oral SGLT2 inhibitor approved by the FDA for treating diabetes in cats is now approved for humans with the disease, drugmaker TheracosBio announced. As an adjunct to diet and exercise, the oral treatment is indicated...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news